Q122 SCS Market revenues were up in the low-single digit YoY, but pandemic-related issues made it a bumpy ride
Among the many topics covered in detail in our comprehensive Q122 Spinal Cord Stimulation Market Recap* are:
2 min read
A Bumpy Ride: Q122 Spinal Cord Stimulation Market Recap
Topics:
Neuro Therapies
Continue Reading
2 min read
Alternative Posterior Fixation: An Interview with Rick Simmons at ISASS 2022
Spinal Elements provides an in-depth look at the Company’s novel Karma Fixation System and what’s next for the technology at ISASS 2022
Spinal Elements Chief Marketing Officer Rick Simmons provides SmartTRAK an indepth look at the Company’s Karma Fixation System, a low-profile alternative to traditional pedicle screw technology, at the International Society of the Advancement for Spinal Surgery (ISASS) 2022 Annual Conference held June 1-4 in the Bahamas. Karma implants consist of a high-performance polymer, enabling an almost completely radiolucent approach to stabilizing the lumbar spine, as an adjunct to fusion and are designed to engage more predictably strong cortical bone. Click on the following video to find out more and see a demonstration of the current technology (7:00 min).
Topics:
Orthopedics
Top Story
Continue Reading
2 min read
New Product Offerings in a Busy Quarter: Q122 Extremities Market Recap
The return of elective procedure volumes, new product offerings and a busy first quarter of acquisitions all supported healthy growth for the Extremities Market
While growth drivers varied for specific companies in Q122, the return of elective procedure volumes helped drive double-digit growth for several market players. Stryker*, the Extremities Market leader, benefited from the return of elective procedures in the US. Its US Foot & Ankle and Upper Extremities business segments contributed to the Company’s US Trauma & Extremities growth during the quarter. Stryker also noted during its earnings call that ...
Among the many topics covered in detail in our comprehensive Q122 Extremities Market Recap* are:
Topics:
Orthopedics
Extremities
Continue Reading
2 min read
Soft Tissue Fixation Rebounds: Q122 Market Recap
After a slow end to 2021, Soft Tissue Fixation bounced back with procedure volumes rebounding in the first quarter of 2022. With 2021 being a year of ups and downs due to the COVID pandemic, staffing shortages and supply chain issues, the start of 2022 looked to be no different. However, even though the quarter started off a bit sluggish, it picked up steam quickly and ended on a positive note with worldwide Soft Tissue Fixation revenues up +7.5% over Q121.
Among the many topics covered in detail in our comprehensive Q122 Soft Tissue Fixation Market Recap* are:
3 min read
Opportunities in Neuromodulation: Abbott at INS 2022
Ryan Lakin, Abbott DVP of R&D, discusses opportunities in neuromodulation in an interview with SmartTRAK at INS 2022
Topics:
Neuro Therapies
Continue Reading
2 min read
Revenues on the Rise: Q122 US Surgical Matrices Market Recap
Surgical matrices procedures appear back to near pre-pandemic levels, with revenues on the rise
With elective procedures in the United States mostly back at pre-pandemic levels, the US Surgical Matrices Market returned to what had been normal growth in Q122, gaining +5.7% YoY according to SmartTRAK Financial Dashboard. AbbVie* continued to lead the Surgical Matrices Market, though it was approximately flat, while Becton Dickinson* (BD) grew strongly.
Among the many topics covered in detail in our comprehensive Q122 US Surgical Matrices Market Recap* are:
Topics:
Wound Care
Continue Reading
2 min read
Moving Past COVID: Q122 WW Advanced Wound Care Market Recap
WW Advanced Wound Care growth settles to a traditional mid-single digit growth rate as global wound care moves past COVID-19.
Topics:
Wound Care
Continue Reading
2 min read
The Effect of Clinical Trial Investment On Hernia Matrices Revenues
SmartTRAK investigates recent trends in hernia repair clinical trials and how these trends relate to competition in the hernia repair market. Using a new SmartTRAK tool to analyze data in clinicaltrials.gov, SmartTRAK describes shifting trends in hernia repair research with company-sponsored studies and randomized controlled trials (RCTs)
Topics:
Wound Care
Continue Reading
2 min read
SmartTRAK is Seeking an Account Manager-Customer Success
Are you looking for a position that gives you a big picture view of everything that is going on in the world of life sciences? Do you have business experience in the medical device industry? If so, we would love to talk with you.
We are BioMedGPS, the creators of the SmartTRAK platform. We are the leading strategic advisory and healthcare analytics provider in the life sciences industry. Our team is once again expanding and seeking an Account Manager who can grow with us. The Account Manager will be responsible for creating and maintaining strategic relationships with our medical device clients. 
Topics:
SmartTRAK News
Continue Reading
2 min read
Procedure Volume Recovery Isn't The Only Trend: Q122 Total Joints Market Recap
Procedure volume recovery is not the only trend on SmartTRAK’s radar
Procedure volume recovery continues to be a trend on everyone’s radar from industry execs to healthcare providers. In Q122, the Knee Replacement Market in the US seemed to experience a much stronger recovery than Hips based on YoY growth rates, according to SmartTRAK Financial Dashboard. However, Knees faced a much easier YoY comp as more knee procedures were postponed in Q121 compared to hips due to their more elective nature. Putting this into perspective, US Hip Market growth along with Knees reinforced the feeling that 2022 procedures will be closer to “normal” as the Total Joints Market recovers from the downsizing caused by COVID. And, as the industry’s bandwidth for focusing on the pandemic decreases, the emphasis on other trends grows.
Among the many topics covered in detail in our comprehensive Q122 Total Joints Market Recap* are:
Topics:
Orthopedics
Total Joints
Continue Reading
